Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight loss drugs Mounjaro and Zepbound, in a matter of days. That’s because a ...

The offer may show employers how hard drug manufacturers will compete based on price, in at least some situations.

Compounding pharmacies stepped in to fill the gaps, as permitted by law during shortages, and millions of Americans turned to them for affordable, copycat drugs. But the US Food and Drug ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

The U.S. Food and Drug Administration said on Monday it will not take action against compounding pharmacies making copies of ...

After being exposed to toxins from the LA fires, some firefighters are turning to a compounded breathing drug, but it's hard ...

A federal judge’s ruling restricts compounding pharmacies from producing generic Zepbound, sparking concerns over affordability ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...